Norges Bank’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.5M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $29.2M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $22.6M | Sell |
|
|||||
|
2024
Q1 | $33.5M | Sell |
|
|||||
|
2023
Q4 | $46.8M | Buy |
|
|||||
|
2023
Q3 | $13.1M | Sell |
|
|||||
|
2023
Q2 | $13.1M | Hold |
|
|||||
|
2023
Q1 | $12.6M | Sell |
|
|||||
|
2022
Q4 | $7.32M | Hold |
|
|||||
|
2022
Q3 | $9.55M | Hold |
|
|||||
|
2022
Q2 | $8.72M | Sell |
|
|||||
|
2022
Q1 | $11.1M | Buy |
|
|||||
|
2021
Q4 | $15M | Buy |
|
|||||
|
2021
Q3 | $39.1M | Buy |
|
|||||
|
2021
Q2 | $50.3M | Buy |
|
|||||
|
2021
Q1 | $44.9M | Buy |
|
|||||
|
2020
Q4 | $45M | Buy |
|
|||||
|
2020
Q3 | $21.5M | Buy |
|
|||||
|
2020
Q2 | $3.97M | Hold |
|
|||||
|
2020
Q1 | $3.53M | Hold |
|
|||||
|
2019
Q4 | $4.27M | Sell |
|
|||||
|
2019
Q3 | $3.22M | Sell |
|
|||||
|
2019
Q2 | $8.09M | Buy |
|